---
figid: PMC4137125__zh40161412100003
figlink: /pmc/articles/PMC4137125/figure/F3/
number: Fig. 3
caption: A schematic representation depicting deleterious effects of overnutrition
  and obesity in the vasculature and targets for DPP-4i. Numbered black circles 1
  through 13 indicate key components of pathology. DPP-4i improve vascular dysfunction
  through GLP-1-dependent and -independent mechanisms through modulation of insulin
  (1) and renin-angiotensin-aldosterone system (RAAS) activation (2) leading to state
  of reactive oxygen species (ROS)-induced ROS and mitochondrial ROS amplification
  (3) and endoplasmic reticular (ER) stress (4). Advanced glycation end products (AGE)
  (5), hyperglycemia (6), and low-grade endotoxemia (7) collectively contribute to
  intracellular oxidative stress. The exacerbated state of oxidative stress induces
  activation of redox sensitive kinases that influence the phosphorylation state of
  insulin receptor substrate-1 (IRS-1) to reduce nitric oxide (NO) generation via
  the phosphoinositide 3-kinase (PI3K)/Akt/endothelial NO synthase (eNOS) signaling
  pathway while favoring signaling through the Shc Ras/MEK/MAPK to increase synthesis
  of endothelin-1 (ET-1). GLP-1 mediated activation of eNOS (8) and cAMP responsive
  element binding protein (CREB) (9) also contribute to vascular protection by DPP-4i.
  Dyslipidemia (10) and dysfunctional immunity (11) and dysfunctional visceral and
  perivascular adipose tissue (12) further contribute to vascular injury and inflammation.
  Thus the interaction of vascular cells, immune cells and adipose tissue causes abnormalities
  in vascular function and remodeling (13). DPP-4i (indicated by yellow boxes) modulate
  different components of pathways that could act to improve vascular function. RAGE,
  receptor for AGE; TLR, Toll-like receptor; Treg, regulatory T cells; Th, T-helper
  cells; WBC, white blood cell; MCP-1, monocyte chemoattractant protein-1; Ox-LDL,
  oxidized LDL; NOX, NADPH oxidase; AT1R, angiotensin type 1 receptor; MR, mineralocorticoid
  receptor; EC, endothelial cell; Ets-1, E26 transformation-specific-1; Ser P, serine
  phosphorylation; Tyr P, tyrosine phosphorylation; PDK1, 3-phosphoinositide-dependent
  protein kinase-1; AMPK, AMP-activated protein kinase; AC, adenylate cyclase; HO-1,
  hemoxygenase-1; NQQ1, quinine reductase.
pmcid: PMC4137125
papertitle: Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular
  system.
reftext: Annayya R. Aroor, et al. Am J Physiol Heart Circ Physiol. 2014 Aug 15;307(4):H477-H492.
pmc_ranked_result_index: '166250'
pathway_score: 0.931707
filename: zh40161412100003.jpg
figtitle: Schematic representation depicting deleterious effects of overnutrition
  and obesity in the vasculature and targets for DPP-4i
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4137125__zh40161412100003.html
  '@type': Dataset
  description: A schematic representation depicting deleterious effects of overnutrition
    and obesity in the vasculature and targets for DPP-4i. Numbered black circles
    1 through 13 indicate key components of pathology. DPP-4i improve vascular dysfunction
    through GLP-1-dependent and -independent mechanisms through modulation of insulin
    (1) and renin-angiotensin-aldosterone system (RAAS) activation (2) leading to
    state of reactive oxygen species (ROS)-induced ROS and mitochondrial ROS amplification
    (3) and endoplasmic reticular (ER) stress (4). Advanced glycation end products
    (AGE) (5), hyperglycemia (6), and low-grade endotoxemia (7) collectively contribute
    to intracellular oxidative stress. The exacerbated state of oxidative stress induces
    activation of redox sensitive kinases that influence the phosphorylation state
    of insulin receptor substrate-1 (IRS-1) to reduce nitric oxide (NO) generation
    via the phosphoinositide 3-kinase (PI3K)/Akt/endothelial NO synthase (eNOS) signaling
    pathway while favoring signaling through the Shc Ras/MEK/MAPK to increase synthesis
    of endothelin-1 (ET-1). GLP-1 mediated activation of eNOS (8) and cAMP responsive
    element binding protein (CREB) (9) also contribute to vascular protection by DPP-4i.
    Dyslipidemia (10) and dysfunctional immunity (11) and dysfunctional visceral and
    perivascular adipose tissue (12) further contribute to vascular injury and inflammation.
    Thus the interaction of vascular cells, immune cells and adipose tissue causes
    abnormalities in vascular function and remodeling (13). DPP-4i (indicated by yellow
    boxes) modulate different components of pathways that could act to improve vascular
    function. RAGE, receptor for AGE; TLR, Toll-like receptor; Treg, regulatory T
    cells; Th, T-helper cells; WBC, white blood cell; MCP-1, monocyte chemoattractant
    protein-1; Ox-LDL, oxidized LDL; NOX, NADPH oxidase; AT1R, angiotensin type 1
    receptor; MR, mineralocorticoid receptor; EC, endothelial cell; Ets-1, E26 transformation-specific-1;
    Ser P, serine phosphorylation; Tyr P, tyrosine phosphorylation; PDK1, 3-phosphoinositide-dependent
    protein kinase-1; AMPK, AMP-activated protein kinase; AC, adenylate cyclase; HO-1,
    hemoxygenase-1; NQQ1, quinine reductase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - MAPK3
  - PRKAG2
  - AKT1
  - AKT2
  - MAPK1
  - PRKAB1
  - PRKAG3
  - ADIPOQ
  - AKT3
  - NOS3
  - MAP2K1
  - PRKAA2
  - ATF2
  - MAPK10
  - ICAM1
  - CREB1
  - CCL2
  - MMP2
  - NFKB1
  - MAP2K2
  - MAPK14
  - TLR6
  - TLR7
  - TLR8
  - MAPK8
  - MAPK11
  - MAPK9
  - TLR1
  - TLR2
  - TLR4
  - TLR5
  - TLR10
  - PRKAB2
  - PRKAG1
  - PIK3R4
  - AR
  - CAD
  - CREB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - CREM
  - CREB3L4
  - ATF1
  - CREB3L3
  - IL6
  - PDK1
  - DPP4
  - PRKACG
  - PRKAR1A
  - PRKAR1B
  - RAF1
  - BRAF
  - EDN1
  - ETS1
  - GLP1R
  - HRAS
  - HMOX1
  - CREB3L1
  - CREB5
  - MAPK12
  - TLR3
  - TH
  - PIK3R6
  - PIK3R5
  - PIK3R3
  - TLR9
  - ARAF
  - PIK3CG
  - PRKACA
  - PRKAR2A
  - CREB3L2
  - PRKAR2B
  - TYRP1
  - PRKACB
  - TYR
  - TGFB1
  - AGER
  - NRAS
  - KRAS
  - SHC4
  - IRS1
  - MAPK13
  - SHC2
  - SHC3
  - SHC1
  - ser
  - superoxide
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: eNOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MCP-1,TGFB-1,ICAM-1,MMP-2
  symbol: ICAM1
  source: hgnc_symbol
  hgnc_symbol: ICAM1
  entrez: '3383'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: TTNF-a,IL-6,MCP-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AT,R
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: CAD
  symbol: CAD
  source: hgnc_symbol
  hgnc_symbol: CAD
  entrez: '790'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: TTNF-a,IL-6,MCP-1
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: DPP-4
  symbol: DPP4
  source: hgnc_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ET-1
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: Ets-1
  symbol: ETS-1
  source: hgnc_alias_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: GLP-1R
  symbol: GLP-1R
  source: hgnc_alias_symbol
  hgnc_symbol: GLP1R
  entrez: '2740'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: HO-1
  symbol: HO-1
  source: hgnc_alias_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: Th,
  symbol: TH
  source: hgnc_symbol
  hgnc_symbol: TH
  entrez: '7054'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: TyrP
  symbol: TYRP
  source: hgnc_prev_symbol
  hgnc_symbol: TYRP1
  entrez: '7306'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Tyr
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: TGFB-1,
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: MẶPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
chemicals:
- word: ser
  source: MESH
  identifier: D012694
- word: superoxide
  source: MESH
  identifier: D013481
- word: Tyr
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
